dfcibreastonc.bsky.social
Patient-centered care, clinical trials & translational research on breast cancer @danafarber.bsky.social and Harvard Medical School. Appts: 877-442-3324, Clinical trials: 877-338-7425
👤 Joined on 05 December 2024
Followers
Following
Total Posts
@dfcibreastonc.bsky.socialPlease join @ptarantinomd.bsky.social social to learn about updates on treatment and research for metastatic breast cancer from the 2025 @ascocancer.bsky.social Conference. For more information and to register, please visit bit.ly/4lprw7N.
Show PostInflammatory breast cancer, a rare and aggressive form of breast cancer, didn’t stop scuba diver Stephanie Lafontaine from pursuing her passions. Learn more about her story: bit.ly/3FYdF8I
Show PostHonored and excited to receive the CRI Lloyd Old STAR award. I can barely believe it! Thanks to everyone in my lab and all my collaborators at DFCI, HMS and beyond @cancerresearchinst.bsky.social @dfcibreastonc.bsky.social @danafarber.bsky.social @harvardmed.bsky.social
Show PostGreat to stop by #USCAP25 this afternoon to support our team’s work using #MachineLearning to characterize the tumor microenvironment in post-surgical #TNBC specimens after neoadjuvant chemo. @dfcibreastonc.bsky.social @uscap.org
Show PostThank you to @stolaney1.bsky.social @dfcibreastonc.bsky.social for inviting me to give the J. Dirk Iglehart, M.D. Visiting Scholar Lecture at the DF/HCC Breast & Gynecologic Cancer Symposium. Incredible science, great friends & connections - what an honor! www.dfhcc.harvard.edu/events/dfhcc...
Show Post